/
/
/

Trident Lifeline Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Dec 2025Sep 2025Jun 2025Dec 2024Sep 2024Jun 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Jun 2022Mar 2022
₹34 Cr₹26 Cr₹31 Cr₹24 Cr₹12 Cr₹15 Cr₹13 Cr₹7 Cr₹5 Cr₹9 Cr₹8 Cr₹9 Cr₹6 Cr₹9 Cr
₹57 L₹5 Cr₹2 Cr₹1 Cr₹56 L₹54 L₹1 Cr₹25 L₹38 L₹33 L₹64 L₹39 L₹90,000₹17 L
₹34 Cr₹30 Cr₹33 Cr₹25 Cr₹12 Cr₹16 Cr₹14 Cr₹7 Cr₹5 Cr₹9 Cr₹9 Cr₹10 Cr₹6 Cr₹9 Cr
₹27 Cr₹23 Cr₹25 Cr₹20 Cr₹8 Cr₹12 Cr₹11 Cr₹6 Cr₹5 Cr₹7 Cr₹7 Cr₹8 Cr₹5 Cr₹7 Cr
₹9 Cr₹10 Cr₹9 Cr₹7 Cr₹5 Cr₹5 Cr₹4 Cr₹2 Cr₹43 L₹2 Cr₹3 Cr₹2 Cr₹87 L₹2 Cr
₹86 L₹1 Cr₹99 L₹1 Cr₹55 L₹50 L₹49 L₹15 L₹9 L₹10 L₹15 L₹13 L₹8 L₹7 L
₹7 Cr₹6 Cr₹7 Cr₹4 Cr₹3 Cr₹4 Cr₹3 Cr₹1 Cr₹28 L₹2 Cr₹2 Cr₹2 Cr₹70 L₹2 Cr
₹5 Cr₹5 Cr₹5 Cr₹3 Cr₹3 Cr₹3 Cr₹2 Cr₹1 Cr₹62 L₹1 Cr₹2 Cr₹2 Cr₹70 L₹3 Cr

Share Price Live Stats

Open (₹)279.00
Volume (₹)33,000.00
High (₹)301.00
Upper Circuit327.20
Low (₹)275.10
Lower Circuit218.20
Prev Close272.70
52W High (₹)328.00
Price300.40
52W Low (₹)229.95

Share Market Cap & Key Ratios Overview

M.Cap (₹)326.07 Cr
Div. Yield (%)0.00
PE Ratio17.12
Debt to Equity0.87
Price to Book4.78
Book Value53.76
EPS (TTM)15.92
Face Value10.00
ROE (%)18.78

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMA-ANSE
DIVISLAB-ANSE
TORNTPHARM-ANSE
ZYDUSLIFE-ANSE
CIPLA-ANSE
LAURUSLABS-ANSE
LUPIN-ANSE
MANKIND-ANSE
DRREDDY-ANSE
AUROPHARMA-ANSE
TLL-MNSE
LTP
1W Low
1W High
Market cap (₹)
1899.85-20.25 (-1.05%)
1896.30
1964.85
4,56,833Cr
9137-132 (-1.42%)
9051.85
9296
2,45,426Cr
4837.35-197.65 (-3.93%)
4822.25
5049
1,87,320Cr
1129.8-57.2 (-4.82%)
1126
1191.45
1,13,217Cr
1380.3-37.7 (-2.66%)
1376
1426.20
1,12,212Cr
1843.05-92.25 (-4.77%)
1812
1947.90
1,01,155Cr
2111-64 (-2.94%)
2107.35
2209
97,626Cr
2331.35-56.05 (-2.35%)
2323.15
2407.40
96,859Cr
1157-20.8 (-1.77%)
1155
1179.90
96,406Cr
1653.55+3.55 (0.22%)
1623.05
1706.70
93,614Cr
300.4+33.05 (12.36%)
268
301
326Cr

Key Highlights of Trident Lifeline Ltd’s P&L

In 2025-03-31, Trident Lifeline Ltd reported total revenue of ₹95.2Cr, compared with ₹46.71Cr in 2024-03-31, reflecting Trident Lifeline Ltd turnover.

Depreciation was ₹5.49Cr and finance costs were ₹4.14Cr in 2025-03-31

Profit Before Tax (PBT) has been ₹13.61Cr in 2025-03-31 as compared to ₹8.7Cr in 2024-03-31.

Net Profit (PAT) was ₹11.75Cr in 2025-03-31 compared with ₹6.34Cr in 2024-03-31.

Earnings per share (EPS) were ₹10.22 in 2025-03-31, compared with ₹5.52 in 2024-03-31.